These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 22568669

  • 21. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J, Matsuyama H, Yamamoto Y, Hara T, Kawai Y, Sakano S, Ohmi C, Gondo T, Naito K.
    BJU Int; 2008 Aug 05; 102(5):572-5. PubMed ID: 18485032
    [Abstract] [Full Text] [Related]

  • 22. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N, Kikuchi E, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakamura S, Oya M.
    BJU Int; 2013 May 05; 111(6):857-64. PubMed ID: 22757942
    [Abstract] [Full Text] [Related]

  • 23. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
    Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF, French National Database on Upper Tract Tumors, Upper Tract Urothelial Carcinoma Collaboration.
    J Urol; 2013 May 05; 189(5):1662-9. PubMed ID: 23103802
    [Abstract] [Full Text] [Related]

  • 24. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy.
    Kusuda Y, Miyake H, Terakawa T, Kondo Y, Miura T, Fujisawa M.
    Urol Oncol; 2013 Aug 05; 31(6):899-903. PubMed ID: 21824792
    [Abstract] [Full Text] [Related]

  • 25. Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome.
    Luo HL, Chen YT, Chuang YC, Cheng YT, Lee WC, Kang CH, Chiang PH.
    BJU Int; 2014 May 05; 113(5b):E144-9. PubMed ID: 24274691
    [Abstract] [Full Text] [Related]

  • 26. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.
    Urology; 2010 Feb 05; 75(2):328-32. PubMed ID: 20018349
    [Abstract] [Full Text] [Related]

  • 27. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Liu Y, Lu J, Hong K, Huang Y, Ma L.
    Urol Oncol; 2014 Feb 05; 32(2):146-52. PubMed ID: 23628312
    [Abstract] [Full Text] [Related]

  • 28. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.
    Urol Oncol; 2013 Nov 05; 31(8):1643-9. PubMed ID: 22591745
    [Abstract] [Full Text] [Related]

  • 29. Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison.
    Moussa S, Yafi FA, El-Hakim A, Fahmy N, Aprikian A, Tanguay S, Anidjar M, Kassouf W.
    Urol Int; 2010 Nov 05; 84(1):50-5. PubMed ID: 20173369
    [Abstract] [Full Text] [Related]

  • 30. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract.
    Ishikawa S, Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Kubota K, Matsuno Y, Osawa T, Shinno Y, Kumagai A, Togashi M, Matsuda H, Mori T, Nonomura K.
    J Urol; 2010 Sep 05; 184(3):883-7. PubMed ID: 20643446
    [Abstract] [Full Text] [Related]

  • 31. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
    Tanaka N, Kikuchi E, Shirotake S, Kanao K, Matsumoto K, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Ito Y, Kosaka T, Kodaira K, Oyama M, Miyajima A, Momma T, Nakagawa K, Ueno M, Oya M.
    Eur Urol; 2014 Jan 05; 65(1):227-34. PubMed ID: 23219372
    [Abstract] [Full Text] [Related]

  • 32. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    J Urol; 2009 Nov 05; 182(5):2177-81. PubMed ID: 19758662
    [Abstract] [Full Text] [Related]

  • 33. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
    Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF.
    Eur Urol; 2012 Feb 05; 61(2):245-53. PubMed ID: 21975249
    [Abstract] [Full Text] [Related]

  • 34. Expression of stathmin in localized upper urinary tract urothelial carcinoma: correlations with prognosis.
    Lin WC, Chen SC, Hu FC, Chueh SC, Pu YS, Yu HJ, Huang KH.
    Urology; 2009 Dec 05; 74(6):1264-9. PubMed ID: 19800106
    [Abstract] [Full Text] [Related]

  • 35. Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Sakano S, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Kaneda Y, Nasu T, Hashimoto O, Joko K, Baba Y, Shimabukuro T, Suga A, Yamamoto M, Aoki A, Takai K, Yoshihiro S, Matsumura M, Yamaguchi Uro-Oncology Group.
    Ann Surg Oncol; 2013 Dec 05; 20(13):4389-96. PubMed ID: 24046115
    [Abstract] [Full Text] [Related]

  • 36. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF.
    BJU Int; 2006 Dec 05; 98(6):1176-80. PubMed ID: 17125474
    [Abstract] [Full Text] [Related]

  • 37. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
    Hirano D, Okada Y, Nagane Y, Satoh K, Mochida J, Yamanaka Y, Hirakata H, Yamaguchi K, Kawata N, Takahashi S, Henmi A.
    Urol Int; 2012 Dec 05; 89(1):71-7. PubMed ID: 22677699
    [Abstract] [Full Text] [Related]

  • 38. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, Vuksanovic A, Bumbasirevic U, Vukovic I, Dragicevic D, Tulic C.
    BJU Int; 2012 Apr 05; 109(7):1037-42. PubMed ID: 21883837
    [Abstract] [Full Text] [Related]

  • 39. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
    Rink M, Xylinas E, Trinh QD, Lotan Y, Margulis V, Raman JD, Fisch M, Lee RK, Chun FK, Abdennabi J, Seitz C, Pycha A, Zlotta AR, Karakiewicz PI, Babjuk M, Scherr DS, Shariat SF, Upper Tract Urothelial Carcinoma Collaboration (UTUCC).
    BJU Int; 2013 Sep 05; 112(5):623-37. PubMed ID: 23465088
    [Abstract] [Full Text] [Related]

  • 40. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
    Bagrodia A, Kuehhas FE, Gayed BA, Wood CG, Raman JD, Kapur P, Derweesh IH, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V.
    Urology; 2013 May 05; 81(5):972-7. PubMed ID: 23523292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.